The Clorox (CLX) Downgraded by Morgan Stanley to Underweight

Morgan Stanley cut shares of The Clorox (NYSE:CLX) from an equal weight rating to an underweight rating in a research report released on Thursday, Marketbeat Ratings reports. Morgan Stanley currently has $116.00 price target on the stock, down from their prior price target of $126.72. The analysts noted that the move was a valuation call.

CLX has been the topic of several other reports. Barclays restated a hold rating and set a $135.00 price objective on shares of The Clorox in a report on Friday, March 16th. BMO Capital Markets set a $147.00 price objective on The Clorox and gave the stock a buy rating in a report on Monday, February 5th. Bank of America upgraded The Clorox from an underperform rating to a neutral rating and set a $155.00 price objective on the stock in a report on Thursday, January 4th. Zacks Investment Research downgraded The Clorox from a buy rating to a hold rating in a report on Monday, January 22nd. Finally, JPMorgan Chase restated a neutral rating and set a $138.00 price objective (down from $139.00) on shares of The Clorox in a report on Tuesday, March 13th. Five investment analysts have rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the company’s stock. The Clorox presently has an average rating of Hold and an average price target of $134.04.

CLX opened at $114.88 on Thursday. The firm has a market cap of $14,865.93, a price-to-earnings ratio of 21.47, a PEG ratio of 2.45 and a beta of 0.35. The Clorox has a 52 week low of $114.38 and a 52 week high of $150.40. The company has a current ratio of 1.22, a quick ratio of 0.86 and a debt-to-equity ratio of 2.35.

The Clorox (NYSE:CLX) last released its quarterly earnings data on Friday, February 2nd. The company reported $1.23 EPS for the quarter, topping the consensus estimate of $1.22 by $0.01. The company had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.43 billion. The Clorox had a return on equity of 126.70% and a net margin of 13.21%. The Clorox’s quarterly revenue was up .7% on a year-over-year basis. During the same period last year, the business posted $1.14 EPS. equities research analysts forecast that The Clorox will post 5.64 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, May 11th. Stockholders of record on Wednesday, April 25th will be issued a $0.96 dividend. The ex-dividend date of this dividend is Tuesday, April 24th. This is an increase from The Clorox’s previous quarterly dividend of $0.84. This represents a $3.84 dividend on an annualized basis and a dividend yield of 3.34%. The Clorox’s dividend payout ratio (DPR) is currently 62.80%.

Large investors have recently made changes to their positions in the company. Prime Capital Investment Advisors LLC purchased a new position in shares of The Clorox in the 4th quarter valued at $123,000. Tiemann Investment Advisors LLC purchased a new position in shares of The Clorox in the 4th quarter valued at $200,000. Nicholas Hoffman & Company LLC. purchased a new position in shares of The Clorox in the 4th quarter valued at $201,000. Private Asset Management Inc. purchased a new position in shares of The Clorox in the 4th quarter valued at $208,000. Finally, Lourd Capital LLC purchased a new position in shares of The Clorox in the 4th quarter valued at $210,000. Institutional investors and hedge funds own 75.63% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This story was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this story on another domain, it was illegally copied and reposted in violation of US and international trademark and copyright legislation. The correct version of this story can be accessed at https://www.dispatchtribunal.com/2018/04/23/the-clorox-clx-downgraded-by-morgan-stanley-to-underweight.html.

The Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighters and color boosters; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning and disinfecting products under the Clorox, Dispatch, Aplicare, HealthLink, and Clorox Healthcare brands.

Analyst Recommendations for The Clorox (NYSE:CLX)

Receive News & Ratings for The Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Clorox and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply